A clinical study of UTI caused by Multi-Drug Resistant (MDR) uropathogens in a tertiary care hospital
Trial Snapshot
- Phase
- Not Applicable
- Status
- Not yet recruiting
- Enrollment
- 1,500
- Locations
- 1
- Primary Endpoint
- 1. MDR Uropathogens causing UTI
Study Overview
Brief Summary
Urinary Tract Infection (UTI) is a common bacterialinfection, which contributes to a frequent cause of morbidity in out-patientsas well as in hospitalized patients. There are numerous cases ofantimicrobial resistance to the commonly used antibiotics in the developed anddeveloping countries. Resistance to newer and more potent antimicrobialsare no exceptions, thereby making the therapeutic options very limited tocertain antimicrobial agents like carbapenem, colistin and fosfomycin. The updated knowledge and situation of the prevailing bacterial uropathogens thatare multidrug resistant (MDR) is of prime importance for the proper use ofantimicrobial drugs and also for policy making to combat multidrug resistancein UTIs. Antimicrobial resistance surveillance is necessary todetermine the size of the problem and to guide the empirical selection ofantimicrobial agents for treating infected patients. This study is aimed tostudy the profile of MDR uropathogens causing UTI in a tertiary care hospitaland assess their antimicrobial susceptibility pattern, clinical course andoutcome.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 0.00 Day(s) to 90.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •1.Subjects whose urine sample when processed showed significant growth of one or more organisms.
Exclusion Criteria
- •1.Subjects whose urine sample was contaminated.
- •3.Subjects whose urine sample showed insignificant bacteriuria.
Outcomes
Primary Outcomes
1. MDR Uropathogens causing UTI
Time Frame: 6 months
Secondary Outcomes
- 1. Antimicrobial susceptibility pattern(2. Clinical course and outcome)